These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26360976)

  • 21. Contrast-enhanced sonography for the characterisation of hepatocellular carcinomas--correlation with histological differentiation.
    Strobel D; Kleinecke C; Hänsler J; Frieser M; Händl T; Hahn EG; Bernatik T
    Ultraschall Med; 2005 Aug; 26(4):270-6. PubMed ID: 16123920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinoma.
    Numata K; Fukuda H; Miwa H; Ishii T; Moriya S; Kondo M; Nozaki A; Morimoto M; Okada M; Takebayashi S; Maeda S; Nozawa A; Nakano M; Tanaka K
    Eur J Radiol; 2014 Jan; 83(1):95-102. PubMed ID: 24176532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perfusion Characteristics of Hepatocellular Carcinoma at Contrast-enhanced Ultrasound: Influence of the Cellular differentiation, the Tumor Size and the Underlying Hepatic Condition.
    Yang D; Li R; Zhang XH; Tang CL; Ma KS; Guo DY; Yan XC
    Sci Rep; 2018 Mar; 8(1):4713. PubMed ID: 29549368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Irregular Defects in Hepatocellular Carcinomas During the Kupffer Phase of Contrast-Enhanced Ultrasonography with Perfluorobutane Microbubbles: Pathological Features and Metastatic Recurrence After Surgical Resection.
    Nuta J; Shingaki N; Ida Y; Shimizu R; Hayami S; Ueno M; Fukatsu K; Itonaga M; Yoshida T; Maeda Y; Moribata K; Deguchi H; Maekita T; Iguchi M; Kato J; Yamaue H; Tamai H
    Ultrasound Med Biol; 2017 Sep; 43(9):1829-1836. PubMed ID: 28625558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parametric imaging with contrast-enhanced ultrasound for differentiating hepatocellular carcinoma from metastatic liver cancer.
    Yue WW; Wang S; Xu HX; Sun LP; Guo LH; Bo XW; Li XL; Zhao CK; Wang D; Liu BJ
    Clin Hemorheol Microcirc; 2016 Nov; 64(2):177-188. PubMed ID: 27258196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CT prediction of histological grade of hypervascular hepatocellular carcinoma: utility of the portal phase.
    Nishie A; Yoshimitsu K; Okamoto D; Tajima T; Asayama Y; Ishigami K; Kakihara D; Nakayama T; Takayama Y; Shirabe K; Fujita N; Honda H
    Jpn J Radiol; 2013 Feb; 31(2):89-98. PubMed ID: 23070581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocellular carcinoma in otherwise sonographically normal liver.
    Naganuma H; Ishida H; Ogawa M; Sato T; Sageshima M; Suzuki K; Ohyama Y
    J Clin Ultrasound; 2019 Jul; 47(6):325-330. PubMed ID: 30484875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical utility of sequential imaging of hepatocellular carcinoma by contrast-enhanced power Doppler ultrasonograpy.
    Suzuki Y; Fujimoto Y; Hosoki Y; Suzuki M; Sakurai S; Ohhira M; Saito H; Kohgo Y
    Eur J Radiol; 2003 Nov; 48(2):214-9. PubMed ID: 14680917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histological grade of hepatocellular carcinoma correlates with arterial enhancement on gadoxetic acid-enhanced and diffusion-weighted MR images.
    Chang WC; Chen RC; Chou CT; Lin CY; Yu CY; Liu CH; Chou JM; Hsu HH; Huang GS
    Abdom Imaging; 2014 Dec; 39(6):1202-12. PubMed ID: 24869790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of hepatocellular carcinoma by contrast-enhanced ultrasound with perfluorobutane microbubbles: comparison with dynamic CT.
    Mandai M; Koda M; Matono T; Nagahara T; Sugihara T; Ueki M; Ohyama K; Murawaki Y
    Br J Radiol; 2011 Jun; 84(1002):499-507. PubMed ID: 20959373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Identification the invasion range of hepatocellular carcinoma by contrast-enhanced ultrasound].
    Zeng YR; Chen MH; Yan K; Liao SR; Dai Y; Yang W; Li JY
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3294-8. PubMed ID: 17313816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.
    Quaia E; De Paoli L; Angileri R; Pizzolato R; Cabibbo B; Cova MA
    Abdom Imaging; 2013 Dec; 38(6):1245-53. PubMed ID: 24026173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CEUS: An essential component in a multimodality approach to small nodules in patients at high-risk for hepatocellular carcinoma.
    Jang HJ; Kim TK; Burns PN; Wilson SR
    Eur J Radiol; 2015 Sep; 84(9):1623-35. PubMed ID: 26092406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrast-enhanced ultrasound features of histologically proven small (≤20 mm) liver metastases.
    Dong Y; Zhang XL; Mao F; Huang BJ; Si Q; Wang WP
    Scand J Gastroenterol; 2017 Jan; 52(1):23-28. PubMed ID: 27577113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parametric imaging with contrast-enhanced ultrasound: usefulness for characterization of dynamic effects of microvascularization for hepatocellular carcinoma and focal nodular hyperplasia.
    Zheng SG; Xu HX; Liu LN; Wang Y; Zhang YF; Guo LH; Liu C; Xu JM; Sun LP; Wu J
    Clin Hemorheol Microcirc; 2013; 55(3):375-89. PubMed ID: 23271200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium.
    Hayashi M; Matsui O; Ueda K; Kawamori Y; Kadoya M; Yoshikawa J; Gabata T; Takashima T; Nonomura A; Nakanuma Y
    AJR Am J Roentgenol; 1999 Apr; 172(4):969-76. PubMed ID: 10587130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between SonoVue enhancement in CEUS, HCC differentiation and HCC diameter: analysis of 130 patients with hepatocellular carcinoma (HCC).
    von Herbay A; Vogt C; Westendorff J; Häussinger D; Gregor M
    Ultraschall Med; 2009 Dec; 30(6):544-50. PubMed ID: 19998208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High mechanical index post-contrast ultrasonography improves tissue structural display of hepatocellular carcinoma.
    Chen MH; Yang W; Dai Y; Wu W
    Chin Med J (Engl); 2005 Dec; 118(24):2046-51. PubMed ID: 16438901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging.
    Sano K; Ichikawa T; Motosugi U; Sou H; Muhi AM; Matsuda M; Nakano M; Sakamoto M; Nakazawa T; Asakawa M; Fujii H; Kitamura T; Enomoto N; Araki T
    Radiology; 2011 Dec; 261(3):834-44. PubMed ID: 21998047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.